LOC646853 Inhibitors
Chemical inhibitors of LOC646853 employ various mechanisms to modulate the activity of this protein by targeting specific signaling pathways and enzymes responsible for its regulation. Staurosporine is a broad-spectrum kinase inhibitor that can inhibit the activity of a wide range of protein kinases, which may include those responsible for phosphorylating LOC646853, thus preventing its activation. Similarly, Bisindolylmaleimide I, a specific inhibitor of protein kinase C, can suppress the phosphorylation and subsequent activation of LOC646853 if PKC is involved in its regulation. LY294002 and Wortmannin both act as PI3K inhibitors; by blocking this kinase, they can prevent PI3K-related activation of LOC646853, assuming the protein's activity relies on PI3K signaling. Rapamycin, by inhibiting mTOR, can also suppress LOC646853 if mTOR signaling is necessary for its function.
Further, PP2 targets Src family kinases, which may phosphorylate LOC646853, thereby potentially inhibiting its activation. PD98059 and U0126 are both inhibitors of MEK, with the latter specifically targeting MEK1/2; they can impede the MAPK/ERK pathway and, if LOC646853 is a downstream target, can suppress its activity. SP600125, by inhibiting JNK, can prevent phosphorylation events that might activate LOC646853, assuming JNK is a regulatory kinase for LOC646853. SB203580, an inhibitor of p38 MAP kinase, can similarly inhibit LOC646853 if it is regulated by p38 MAPK-mediated phosphorylation. Gefitinib acts upstream by inhibiting EGFR tyrosine kinase, which can lead to the downregulation of LOC646853 if its activation is EGFR-dependent. Lastly, Imatinib, by targeting Bcr-Abl and other kinases, can inhibit LOC646853 if these kinases participate in its phosphorylation and activation. Each of these inhibitors targets distinct kinases or signaling pathways, but all converge on the common goal of inhibiting the activity of LOC646853 by preventing its necessary phosphorylation and activation events.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Inhibition of specific kinases that phosphorylate LOC646853 could prevent its activation, leading to a reduction in its activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of protein kinase C (PKC). If LOC646853 is activated by PKC-mediated phosphorylation, this compound would inhibit LOC646853 activity by preventing its phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K). By inhibiting PI3K, this compound would prevent the activation of the AKT pathway, which could be essential for the activation of LOC646853, thus inhibiting the protein’s activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Given that Src family kinases might play a role in the phosphorylation and subsequent activation of LOC646853, PP2 could inhibit its activity by preventing these phosphorylation events. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK), which is involved in the MAPK/ERK pathway. By inhibiting MEK, PD98059 would prevent the activation of ERK, potentially inhibiting downstream proteins like LOC646853. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), part of the MAPK pathway. Inhibition of JNK could prevent the phosphorylation and activation of substrates, including LOC646853, leading to the inhibition of its activity if JNK is involved in LOC646853 regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. If LOC646853 is regulated by p38 MAPK-mediated phosphorylation, SB203580 could reduce its activity by preventing this phosphorylation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K. Similar to LY294002, if LOC646853 activity is PI3K-dependent, Wortmannin would functionally inhibit LOC646853 by preventing the necessary PI3K signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key protein in the PI3K/AKT/mTOR pathway. If LOC646853 requires mTOR signaling for its activity, Rapamycin would functionally inhibit LOC646853 by preventing downstream signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream of ERK in the MAPK pathway. Inhibition of MEK1/2 by U0126 could lead to functional inhibition of LOC646853 if the protein’s activity is dependent on the MAPK/ERK pathway. | ||||||